SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Compound Dissolves HIV on Contact, Texas A&M University Study
November 29, 2011
 · 
1 min read
Lone Star Bio
Chemists Cram Two Million Nanorods Into Single Cancer Cell, Rice University Study
November 18, 2011
 · 
1 min read
Lone Star Bio
Parkinsonian Worms May Hold the Key to Identifying Drugs for Parkinson’s Disease, University of Texas Study
November 11, 2011
 · 
1 min read
Lone Star Bio
Facial Blemishes Hurt Chance of Landing Job, Rice University Study
November 10, 2011
 · 
1 min read
Lone Star Bio
“Fake Marijuana” May Trigger Heart Trouble in Teens, Children’s Medical Center Dallas Study
November 9, 2011
 · 
1 min read
Lone Star Bio
Fatherhood Can Help Change a Man’s Bad Habits, University of Houston Study
November 8, 2011
 · 
1 min read
Lone Star Bio
Metabolic Protein Plays Unexpected Role in Tumor Cell Formation and Growth, MD Anderson Study
November 7, 2011
 · 
1 min read
Lone Star Bio
Suicide Switch May Pave Way for Safer Cancer Treatment, Baylor College of Medicine Study
November 3, 2011
 · 
1 min read
Lone Star Bio
Blood Vessel Mapping Reveals Four New ‘ZIP Codes’, MD Anderson Study
November 3, 2011
 · 
1 min read
Lone Star Bio
Could Listening to Mozart Help Doctors Spot Colon Polyps? University of Texas Study
November 2, 2011
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Press Releases
Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care
June 24, 2026
 · 
6 min read
Load More